SCHEMBL26548247

SCHEMBL26548247

Fc1ccc(-c2ccc3cc(-c4ccc(-c5cccc6c5oc5ccccc56)nc4)ccc3c2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 2/20 0.43
L3MBTL1 Q9Y468 1/20 0.40
GABRP O00591 1/20 0.37
GABRD O14764 1/20 0.37
TNKS O95271 1/20 0.37
PARP1 P09874 1/20 0.37
GABRA1 P14867 1/20 0.37
GABRB1 P18505 1/20 0.37
GABRG2 P18507 1/20 0.37
GABRB3 P28472 1/20 0.37
GABRA5 P31644 1/20 0.37
GABRA3 P34903 1/20 0.37
GABRA2 P47869 1/20 0.37
GABRB2 P47870 1/20 0.37
GABRA4 P48169 1/20 0.37
GABRE P78334 1/20 0.37
GABRA6 Q16445 1/20 0.37
GABRG1 Q8N1C3 1/20 0.37
GABRG3 Q99928 1/20 0.37
TNKS2 Q9H2K2 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26548766 0.97 ALOX5 (0.43) ALOX5L3MBTL1GABRPGABRDTNKS
SCHEMBL17212568 0.93 ALOX5 (0.49) ALOX5PIK3CDPIK3CBPRKDCCYP1A2
SCHEMBL26549265 0.93 ALOX5 (0.40) ALOX5L3MBTL1GABRPGABRDTNKS
SCHEMBL17212576 0.89 ALOX5 (0.48) ALOX5L3MBTL1PIK3CDPIK3CBPRKDC
SCHEMBL26565106 0.89 ALOX5 (0.43) ALOX5PGRPIK3CDPIK3CBPRKDC
SCHEMBL26551827 0.89 ALOX5 (0.43) ALOX5TNKSPARP1TNKS2CASP3
SCHEMBL26551836 0.89 ALOX5 (0.43) ALOX5PIK3CDPIK3CBPRKDCCYP1A2
SCHEMBL26548251 0.88 ALOX5 (0.41) ALOX5PGRMEN1KMT2ACYP1A1
SCHEMBL26548255 0.88 ALOX5 (0.43) ALOX5L3MBTL1PIK3CDPIK3CBPRKDC
SCHEMBL17212639 0.87 ALOX5 (0.51) ALOX5L3MBTL1PIK3CDPIK3CBPRKDC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230337527-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME LAPTO CO., LTD. (KR) 2023-10-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230337527-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME AOC1, ODC1, PIEZO1 ALOX5 1577/4885L3MBTL1 1375/4885GABRP 4875/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.